NCT01576666 · Interventional trial
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
Overall registry status Completed
Phase 1
Conditions Advanced Pancreatic Adenocarcinoma, Advanced Solid Tumors, Dose Escalation, Gastric Cancer, Gastroesophageal Junction Cancer, Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Preliminary Efficacy, Recurrent Glioblastoma Multiforme, Safety, Triple Negative Metastatic Breast Cancer
Delaware Valley sites
- Fox Chase Cancer Center FCCC · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory